These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23635405)

  • 1. Plasma fatty acid lipidomics in amnestic mild cognitive impairment and Alzheimer's disease.
    Iuliano L; Pacelli A; Ciacciarelli M; Zerbinati C; Fagioli S; Piras F; Orfei MD; Bossù P; Pazzelli F; Serviddio G; Caltagirone C; Spalletta G
    J Alzheimers Dis; 2013; 36(3):545-53. PubMed ID: 23635405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased apoptosis in the platelets of patients with Alzheimer's disease and amnestic mild cognitive impairment.
    Zhao S; Zhao J; Zhang T; Guo C
    Clin Neurol Neurosurg; 2016 Apr; 143():46-50. PubMed ID: 26895209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased serum levels of the angiogenic factors VEGF and TGF-β1 in Alzheimer's disease and amnestic mild cognitive impairment.
    Huang L; Jia J; Liu R
    Neurosci Lett; 2013 Aug; 550():60-3. PubMed ID: 23827227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of angiotensin-converting enzyme functional gene I/D polymorphism with amnestic mild cognitive impairment.
    Zhang Z; Deng L; Yu H; Shi Y; Bai F; Xie C; Yuan Y; Jia J; Zhang Z
    Neurosci Lett; 2012 Apr; 514(1):131-5. PubMed ID: 22405893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered complexity of resting-state BOLD activity in Alzheimer's disease-related neurodegeneration: a multiscale entropy analysis.
    Ren P; Ma M; Xie G; Wu Z; Wu D;
    Aging (Albany NY); 2020 Jul; 12(13):13571-13582. PubMed ID: 32649309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer's disease.
    Olazarán J; Gil-de-Gómez L; Rodríguez-Martín A; Valentí-Soler M; Frades-Payo B; Marín-Muñoz J; Antúnez C; Frank-García A; Acedo-Jiménez C; Morlán-Gracia L; Petidier-Torregrossa R; Guisasola MC; Bermejo-Pareja F; Sánchez-Ferro Á; Pérez-Martínez DA; Manzano-Palomo S; Farquhar R; Rábano A; Calero M
    J Alzheimers Dis; 2015; 45(4):1157-73. PubMed ID: 25649659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amnestic mild cognitive impairment and conversion to Alzheimer's disease: insulin resistance and glycoxidation as early biomarker clusters.
    Monacelli F; Borghi R; Cammarata S; Nencioni A; Piccini A; Tabaton M; Odetti P
    J Alzheimers Dis; 2015; 45(1):89-95. PubMed ID: 25471189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of education on the progression of early- versus late-stage mild cognitive impairment.
    Ye BS; Seo SW; Cho H; Kim SY; Lee JS; Kim EJ; Lee Y; Back JH; Hong CH; Choi SH; Park KW; Ku BD; Moon SY; Kim S; Han SH; Lee JH; Cheong HK; Na DL
    Int Psychogeriatr; 2013 Apr; 25(4):597-606. PubMed ID: 23207181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The feasibility of utilizing plasma MiRNA107 and BACE1 messenger RNA gene expression for clinical diagnosis of amnestic mild cognitive impairment.
    Wang T; Chen K; Li H; Dong S; Su N; Liu Y; Cheng Y; Dai J; Yang C; Xiao S
    J Clin Psychiatry; 2015 Feb; 76(2):135-41. PubMed ID: 25742200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hard Test Your Memory. Evaluation of a short cognitive test to detect mild Alzheimer's disease and amnestic mild cognitive impairment.
    Brown JM; Wiggins J; Dong H; Harvey R; Richardson F; Hunter K; Dawson K; Parker RA
    Int J Geriatr Psychiatry; 2014 Mar; 29(3):272-80. PubMed ID: 23929807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment.
    Wang G; Zhou Y; Huang FJ; Tang HD; Xu XH; Liu JJ; Wang Y; Deng YL; Ren RJ; Xu W; Ma JF; Zhang YN; Zhao AH; Chen SD; Jia W
    J Proteome Res; 2014 May; 13(5):2649-58. PubMed ID: 24694177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease.
    Mah L; Binns MA; Steffens DC;
    Am J Geriatr Psychiatry; 2015 May; 23(5):466-76. PubMed ID: 25500120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease.
    Parker DC; Mielke MM; Yu Q; Rosenberg PB; Jain A; Lyketsos CG; Fedarko NS; Oh ES
    Int J Geriatr Psychiatry; 2013 Feb; 28(2):149-54. PubMed ID: 22539447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer's disease.
    Fonteh AN; Cipolla M; Chiang J; Arakaki X; Harrington MG
    PLoS One; 2014; 9(6):e100519. PubMed ID: 24956173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The shift in the fatty acid composition of the circulating lipidome in Alzheimer's disease.
    Dakterzada F; Jové M; Cantero JL; Mota-Martorell N; Pamplona R; Piñoll-Ripoll G
    Alzheimers Dement; 2024 May; 20(5):3322-3333. PubMed ID: 38534027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer's disease.
    Kobayashi N; Nagata T; Shinagawa S; Oka N; Shimada K; Shimizu A; Tatebayashi Y; Yamada H; Nakayama K; Kondo K
    Biochem Biophys Res Commun; 2013 Jan; 430(3):907-11. PubMed ID: 23261465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saccade deficits in amnestic mild cognitive impairment resemble mild Alzheimer's disease.
    Peltsch A; Hemraj A; Garcia A; Munoz DP
    Eur J Neurosci; 2014 Jun; 39(11):2000-13. PubMed ID: 24890471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion tensor imaging measures of normal appearing white matter in patients who are aging, or have amnestic mild cognitive impairment, or Alzheimer's disease.
    Wang JH; Lv PY; Wang HB; Li ZL; Li N; Sun ZY; Zhao BH; Huang Y
    J Clin Neurosci; 2013 Aug; 20(8):1089-94. PubMed ID: 23787190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma SUMO1 Protein is Elevated in Alzheimer's Disease.
    Cho SJ; Yun SM; Lee DH; Jo C; Ho Park M; Han C; Ho Koh Y
    J Alzheimers Dis; 2015; 47(3):639-43. PubMed ID: 26401699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.